Prescription medication · ACE Inhibitor

benazepril

Also sold as Lotensin. Benazepril is used to treat high blood pressure (hypertension).

Data updated 2026-05-15

7,061
FDA reportsLightly reported
5
InteractionsFew interactions
$0.05
Generic price (NADAC)

What the data shows

benazepril (Lotensin) is a prescription ACE Inhibitor, reported less often than most tracked drugs (7,061 FDA reports), with 5 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

benazepril (Lotensin) is a prescription ACE Inhibitor. Benazepril is used to treat high blood pressure (hypertension).

Benazepril (Lotensin) is a medicine that lowers your blood pressure. Lowering blood pressure helps to prevent strokes and heart attacks.

Drug Pricing (NADAC)

Generic Price

$0.05/unit

Generic Available

Yes (6 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Benazepril is used to treat high blood pressure (hypertension).

Common side effects

Headache, Dizziness, Feeling sleepy

Key warnings

If you become pregnant, stop taking benazepril right away and tell your doctor.

The sections below are summarized in plain English from benazepril's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Benazepril is an ACE inhibitor. It works by relaxing your blood vessels. This makes it easier for your heart to pump blood.

Side Effects (from patient reports)

Based on 7,061 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for benazepril, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for benazepril each year to the FDA Adverse Event Reporting System (FAERS).

0200400600800 199820062009201220152018202120242025 164

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where benazepril sits

benazepril has more FDA adverse-event reports than 31% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is benazepril; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 7,061 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 1998–2025.

Total Reports

7,061

Reports Mentioning Death

572

8.1% of reports — not proof of cause

Hospitalization Reports

2,464

Top Indication

Hypertension

Gender Distribution

Female 3,723 (55%)
Male 3,019 (45%)

Age Distribution

0–17 17
18–44 321
45–64 1,862
65–74 1,197
75+ 1,015

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 NAUSEA 439
2 FATIGUE 408
4 DIZZINESS 382
5 DYSPNOEA 381
6 PAIN 361
7 DIARRHOEA 356
8 HEADACHE 344
9 MYOCARDIAL INFARCTION 310
10 HYPERTENSION 295
11 ASTHENIA 269
12 VOMITING 257
13 ANXIETY 253
14 CEREBROVASCULAR ACCIDENT 248
15 CARDIAC FAILURE CONGESTIVE 240
16 CHEST PAIN 239

Reactions in Death Reports

DEATH 153
COMPLETED SUICIDE 81
MYOCARDIAL INFARCTION 63
RENAL FAILURE 63
PAIN 55
ANXIETY 50
CARDIAC ARREST 48
CARDIAC FAILURE CONGESTIVE 48
RESPIRATORY FAILURE 44
CEREBROVASCULAR ACCIDENT 43

Reactions in Hospitalization Reports

MYOCARDIAL INFARCTION 264
CARDIAC FAILURE CONGESTIVE 207
DYSPNOEA 203
CEREBROVASCULAR ACCIDENT 196
HYPERTENSION 175
CHEST PAIN 172
NAUSEA 171
PAIN 156
CORONARY ARTERY DISEASE 153
DIARRHOEA 148

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

If you become pregnant, stop taking benazepril right away and tell your doctor. This medicine can harm or kill your unborn baby.

Known Drug Interactions

7.4 Dual Blockade of the Renin-Angiotensin System (RAS) Dual Blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not coadminister aliskiren with benazepril hydrochloride in patients with diabetes. Avoid use of aliskiren with benazepril hydrochloride in patients with renal impairment (GFR < 60 ml/min).

Mechanism: These medicines both target the same pathway for blood pressure control, which increases the risk of kidney failure and high potassium. Using them together can cause your blood pressure to fall to unsafe levels.

Hyperkalemia Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia.

Mechanism: Both of these medicines cause the body to hold onto potassium instead of getting rid of it through urine. This can lead to a dangerous buildup of potassium in your blood.

moderate lithium

7 DRUG INTERACTIONS • Diuretics: Excessive drop in blood pressure ( 7.1 ) • Antidiabetics: Increased risk of hypoglycaemia ( 7.2 ) • NSAIDS: Increased risk of renal impairment and loss of antihypertensive efficacy ( 7.3 ) • Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension and hyperkalemia ( 7.4 ) • Lithium: Symptoms of lithium toxicity ( 7.6 ) • Neprilysin Inhibitor: Increased risk of angioedema ( Error! 7.6 Lithium Lithium toxicity has been reported in patients receiving lithium concomitantly with benazepril hydrochloride. Lithium toxicity...

Mechanism: Benazepril can make it harder for your kidneys to remove lithium from your body. This causes lithium to build up to levels that can be poisonous.

moderate amiloride

Hyperkalemia Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia.

Mechanism: These two drugs both prevent the kidneys from flushing out potassium. Taking them together increases the risk that your potassium levels will become too high.

Benazepril Potassium Supplements and Potassium-Sparing Diuretics: Benazepril can attenuate potassium loss caused by thiazide diuretics. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including benazepril, may result in deterioration of renal function, including possible acute renal failure. Monitor renal function...

Mechanism: Taking both of these medications means you are taking the same medicine twice. This can lead to a higher risk of kidney problems or dangerously low blood pressure.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I take benazepril if I am allergic to other ACE inhibitors?
No, you should not take benazepril if you are allergic to any other ACE inhibitor.
Can I take benazepril if I have a history of angioedema?
No, you should not take benazepril if you have a history of angioedema.
Does benazepril interact with other medications?
Yes, benazepril can interact with diuretics, antidiabetics, NSAIDs, lithium and other medicines. Tell your doctor about all the medicines you take.
How long does it take for benazepril to start working?
Benazepril starts working quickly, but it may take several weeks to see the full effect on your blood pressure.
Can I drink alcohol while taking benazepril?
Talk to your doctor about drinking alcohol while taking benazepril, as it can lower your blood pressure further.
What should I do if I experience swelling while taking benazepril?
If you experience swelling of your face, tongue, or throat, stop taking benazepril and seek immediate medical attention.
Can benazepril cause kidney problems?
Benazepril can affect your kidneys, so your doctor will monitor your kidney function.
Can benazepril cause high potassium?
Yes, benazepril can increase your potassium levels, so your doctor will monitor your potassium levels.
Is it safe to take benazepril while breastfeeding?
Talk to your doctor before taking benazepril while breastfeeding.
Can benazepril cause a cough?
Yes, cough is a common side effect of benazepril.
What are the common side effects of benazepril?
The registry lists Headache, Dizziness, Feeling sleepy, Dizziness when standing up among the most-reported FAERS reaction terms for benazepril. The compiled record contains 7,061 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does benazepril interact with other medications?
The registry has 5 documented interaction rows for benazepril. Notable source-record pairings include aliskiren, spironolactone, lithium. These rows are not a complete medication review.
What drug class is benazepril?
benazepril belongs to the ACE Inhibitor drug class. It requires a prescription (Rx). Benazepril is used to treat high blood pressure (hypertension).
What pregnancy or breastfeeding source fields are listed for benazepril?
The FDA label for benazepril contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near benazepril - same-class peers and common alternatives.

Compare benazepril vs acebutolol side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for benazepril: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on benazepril

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for benazepril

The FDA label for benazepril (sold under brand names such as Lotensin) classifies it as a prescription-only medication in the ACE Inhibitor class. Benazepril is used to treat high blood pressure (hypertension). Official labeling lists 4 commonly reported side effects, including Headache, Dizziness, Feeling sleepy.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 7,061 voluntary reports. The database also lists 5 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.05.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: January 12, 2026

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page